Michael Acceptor Compounds as Hemoglobin Oxygen Affinity Modulators for Reversing Sickling of Red Blood CellsKhadijah A. Mohammad, Moustafa E. El‐Araby, Osheiza Abdulmalik et al.|Pharmaceuticals|2025Cited by 1
Potent Antisickling Furaldehyde Analogs for Acute Sickle Cell Therapy: Enhanced Efficacy and Intravenous Formulation PotentialAbdelsattar M. Omar, Martin K. Safo, Moustafa E. El‐Araby et al.|ChemMedChem|2025Cited by 1
Hemoglobin: A Target for Sickle Cell Disease Drug DiscoveryAkua K. Donkor, Martin K. Safo, Y Zhang et al.|Unknown|2026Cited by 0